← Eichor
Condition: Antibody Mediated Rejection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Antibody Mediated Rejection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Use of Extracorporeal Photopheresis in Kidney Transplantation: Effects on Antibody-Mediated Rejection
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT07663669TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients
Phase 3 · 8 location(s) · Vastra Gotaland Region · NCT04561986Treatment of Antibody-Mediated Rejection (ABMR) With CarBel
Phase 1 · 10 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06918990Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab
NA · 1 location(s) · Shahid Beheshti University of Medical Sciences · NCT07006532Daratumumab for Late Antibody-Mediated Rejection
NA · 1 location(s) · University Hospital, Martin · NCT07081126Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
Phase 2 · 55 location(s) · Alexion Pharmaceuticals, Inc. · NCT06744647A Two Part Dose-escalation Safety and Efficacy Study of CID-103 in Adults With Active and Chronic Active Renal Allograft
Phase 1/Phase 2 · 4 location(s) · CASI pharmaceuticals, Inc. · NCT07641426Impact of ExtraCorporeal Phototherapy (ECP) on Auxiliary Follicular T-lymphocytes and Circulating B-lymphocytes During C
NA · 4 location(s) · University Hospital, Angers · NCT04870437Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation
Phase N/A · 11 location(s) · University of Alberta · NCT02812290Biorepository and Registry for Plasma Exchange Patients
Phase N/A · 1 location(s) · Charles M Knudson · NCT05004493Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study,
Phase N/A · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07134491A Prospective Randomized Trial of ECP in Subclinical AMR
NA · 7 location(s) · Medical University of Vienna · NCT06112951A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation
Phase 1 · 2 location(s) · Washington University School of Medicine · NCT06990711CARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart Transplantation
Phase N/A · 4 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06774365
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.